Pierre‐Louis Carron

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 215 citations · Full text

Medicine, Internal Medicine, Nephrology +12

Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy

Frank Bridoux, Pierre‐Louis Carron, Brigitte Pegourié et al. · JAMA · 2017 · 162 citations · Full text

Medicine, Hematology, Nephrology +17

CD4 LYMPHOCYTOPENIA AS A RISK FACTOR FOR SKIN CANCERS IN RENAL TRANSPLANT RECIPIENTS

Pierre‐Louis Carron, Jean-Michel Rebibou, V ronique Fournier et al. · Transplantation · 1998 · 131 citations

Medicine, Dermatology, Immunology +14

Lymphocyte subsets and assessment of cancer risk in renal transplant recipients.

Pierre‐Louis Carron, G Motté, Abdelfatah Ab et al. · PubMed · 2002 · 52 citations

Medicine, Immunology, Oncology +14

Lymphocyte subsets and assessment of cancer risk in renal transplant recipients

Pierre‐Louis Carron, G Motté, Abdelfatah Ab et al. · Transplant International · 2002 · 47 citations

Medicine, Immunology, Oncology +16